Across the recent three months, 14 analysts have shared their insights on Axsome Therapeutics (NASDAQ:AXSM), expressing a variety of opinions spanning from bullish to bearish. In the table below, you’ll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $132.14, a high estimate of $190.00, and a low estimate of $95.00. A decline of 0.18% from the prior average price target is eviden…